trial · primary record
hypofractionated 12x3 Gy + integrated boost 12x4 Gy
Spinal Metastases
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 155 |
| Primary completion | 2029-04 |
| Primary endpoint | tumor control (time up to progression) |
| Registry ID | NCT01849510 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:46.616Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01849510
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.